Nov 23, 2021

BTV Investor Alert Video: Entheon Biomedical Corp. - Treating Addiction

Welcome aboard! Your submission has been received and you are now a member of the MedicalGold.ca community.
Oops! Something went wrong while submitting the form. Please check the format of your entry.
Subscribe to Excellence

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2021) - Entheon Biomedical Corp. (CSE: ENBI) - Researching and developing DMT, one of the most powerful psychedelics in existence, to address substance use disorders related to nicotine, alcohol, and opioids.

If you cannot view the video above, please visit:
https://b-tv.com/investor-alert-entheon-biomedical-treating-addiction-btv-investing-news/

Entheon Biomedical Corp. is being featured on BNN Bloomberg on Nov 22nd to Dec 5th, 2021, throughout the day and evenings.

Entheon Biomedical Corp. (CSE: ENBI)

https://entheonbiomedical.com/

About BTV:

BTV-Business Television is Canada's longest running business show. With Hosts Taylor Thoen and Jessica Katrichak, BTV features emerging companies across the country to bring viewers investment opportunities. BTV also produces News Alerts and branding/ awareness spots for issuers broadcast on BNN Bloomberg, Fox Business News, Bloomberg TV US and Bloomberg Terminals. www.b-tv.com

BTV - Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104650

DISCLAIMER:

The work included in this article is based on current events, technical charts, company news releases, and the author’s opinions. It may contain errors, and you shouldn’t make any investment decision based solely on what you read here. This publication contains forward-looking statements, including but not limited to comments regarding predictions and projections. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. This publication is provided for informational and entertainment purposes only and is not a recommendation to buy or sell any security. Always thoroughly do your own due diligence and talk to a licensed investment adviser prior to making any investment decisions. Junior resource and biotechnology companies can easily lose 100% of their value so read company profiles on www.SEDAR.com for important risk disclosures. It’s your money and your responsibility.

Other News

See All News

Other Articles

See All Articles